DPP4 and type 2 diabetes mellitus: As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may bind to DPP4 (or CD26), which mediates proinflammatory signals, sitagliptin might exert anti-inflammatory effects in patients with T2DM and COVID-19.